Home Business

Sun Pharma up on new support in Taro war

Sun Pharma ended at its intra-day high of Rs 1542, stronger by Rs 38 or 2.5% on the BSE. - Sun TV up on restructuring plans - Nalco up on hike in prices - Sun pharma gets fresh support in Taro battle - Nava Bharat soars on acquiring 65% Zambian coal mine - M&M erases gains, ends down 1% - More support for Sun Pharma in Taro takeover battle The stock had opened at Rs 1513 and touched a high of Rs 1505 during the day. ____________________________________________________________________________________ (Updated at 1150am) Sun Pharmaceutical Industries is up on getting more support from independent advisory firms in its battle to acquire Israeli drug major Taro Pharmaceutical Industries. The stock opened at Rs 1,513 and soared to a high of Rs 1,524. The scrip is now trading at Rs 1,523, up 1% from its previous close. The counter clocked volumes of 5,373 shares as compared to the two-week dailya verage traded volumes of 20,294 shares on the BSE.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Cavin Kare eyeing more overseas markets
Chennai-based fast moving consumer goods firm Cavin Kare Private Limited has planned to double its exports this year by reaching out to new overseas markets like the US and Australia, a top company official said.
Popular Articles
Best furniture stores in nyc

OMCs turn to CPs, debentures as credit needs rise
Oil marketing companies (OMCs) are increasingly going in for debentures and commercial papers for meeting their short-term credit requirements. The largest petroleum marketer, Indian Oil Corporation, has raised around Rs 5,000 crore and Hindustan Petroleum Corporation has raised Rs 2,000 crore through sale of commercial papers (CPs) over the past two months. Bharat Petroleum Corporation recently raised Rs 1,000 crore through debentures.
Polygraphy
A Bolly-good show for Indian cinema
The Indian cinema has witnessed some key changes over the decade. The surge of multiplexes and digital screens, changing methods of distribution & promotion of films and rising actor remuneration — all have redefined the business of Bollywood in India.